 |
|
 |
|||||||||||||||
|
|||||||||||||||||
 |
 |
 |
|
 |
1. Cheyne EH, Cavan DA, Kerr D. 2002. Performance of a continuous glucose monitoring system during controlled hypoglycaemia in healthy volunteers. Diabetes Technology & Therapeutics 4:607-613. 2. Gross TM, Bode, BW, Einhorn D, Kayne DM, Reed JH, White NH, Mastrototaro JJ. 2000. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technology & Therapeutics 2:49-56. 3. Gross TM, Ter Veer A. 2000. Continuous glucose monitoring in previously unstudied population subgroups. Diabetes Technology & Therapeutics 2 (Suppl. 1):S27-34. 4. Gross TM, Mastrotrotaro JJ. 2000. Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technology & Therapeutics 2 (Suppl. 1):S19-26. 5. Monsod TP, Flanagan DE, Rife F, Saenz R, Caprio S, Sherwin RS, Tamborlane WV. 2002. Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care 25(5):889-893. 6. Zavalkoff SR, Polychronakos C. 2002. Evaluation of conventional blood glucose monitoring as an indicator of integrated glucose values using a continuous subcutaneous sensor. Diabetes Care 25(9):1603-1606. 7. Rebrin K, Steil GM, Van Antwerp WP, Mastrototaro JJ. 1998. Reliability of interstitial glucose measurements by subcutaneous glucose sensors in humans [abstract]. In: Diabetologia 41 (Suppl. 1):880. 8. Sharp PS, Krishna S, Rainbow S. 2001. Glycated haemoglobin and continuous glucose monitoring [abstract]. In: Diabetologia; 44 (Suppl. 1):913. 9. Shin JJ, Dangui ND, Kanderian, Jr. S, Gross TM, Mastrototaro JJ. 2002. A new retrospective calibration algorithm (New-RA) for continuous glucose monitoring provides more complete and more accurate CGMS data [abstract]. In: Diabetes 51 (Suppl. 2): 843. 10. Steil GM, Bernaba B, Saad M, Mastrototaro J, Rebrin K. 2000. Accurate determination of plasma glucose during hyper- and hypoglycemia with a subcutaneous glucose sensor [abstract]. In: Diabetes 49 (Suppl. 1):510. Continuous Glucose Monitoring as an Evaluation Method in Clinical Trials 11. Kessler L, Passemard R, Oberholzer J, Benhamou PY, Bucher P, Toso C, Meyer P, Penfornis A, Badet L, Wolf P, Colin C, Morel P, Pinget M, on behalf of the GRAGIL group. 2002. Reduction in blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation. Diabetes Care 25:2256-2262. 12. Levetan C, Want LL, Weyer C, Strobel SA, Crean J, Wang Y, Maggs DG, Kolterman OG, Chandran M, Madalier SR, Henry RR. 2003. Impact of pramlintide on glucose fluctuation and postprandial glucose, glucagons, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps. Diabetes Care 26:1-8. 13. Javor ED, Ilic S, Lee SW. 2001. A qualitative comparison between multiple daily injections and continuous subcutaneous insulin infusion using a continuous glucose monitoring system [abstract]. In: Diabetes 50 (Suppl. 2): 1828 14. Meyer L, Boullu-Sanchis S, Boeckler P, Sibenaler A, Treger M, Pinget M, Jeandidier N. 2002. Comparison of glycemic control in 3 groups of type 1 diabetic patients treated with multiinjections and Lispro (MDI), continuous subcutaneous insulin infusion with Lispro (CSII) or continuous peritoneal insulin infusion (CPII): Data of continuous subcutaneous glucose sensing (CGMS) [abstract]. In: Diabetes 51 (Suppl. 2):502. 15. Adolfsson P, Lindblad B, Jönsson A-G, Andreasson C, Hanas R. 2000. Use of continuous glucose monitoring and microdialysis measurements during physical exercise among adolescents with type 1 diabetes [abstract]. In: Journal of Pediatric Endocrinology & Metabolism 13 (Suppl. 4):32. 16. Kruger D, Marcus AO. 2000. Psychological motivation and patient education: a role for continuous glucose monitoring. Diabetes Technology & Therapeutics 2 (Suppl. 1):S93-97. 17. Brynes AE, Lee JL, Brighton RE, Leeds AR, Dornhorst A, Frost GS. 2003. A low glycemic diet significantly improves 24-h blood glucose profile in people with type 2 diabetes, as assessed using the continuous glucose MiniMed monitor [Letter to the Editor]. Diabetes Care 26:548-549. 18. Carr JM, Corcoran MH. 2002. Continuous glucose monitoring in marathon runners with type 1 diabetes during the 2001 Chicago Marathon [abstract]. In: Diabetes 51 (Suppl. 2):988. 19. Largay J, McMurray R, Sabbah HT, Bode BW, Buse JB. 2001. A pilot study to determine the optimal insulin adjustment and carbohydrate supplementation to perform intense endurance exercise in four cyclists with type 1 diabetes [abstract]. In: Diabetes 50 (Suppl. 2):2030. 20. Oyibo SO, Prasad YDM, Jackson NJ, Jude EB, Boulton AJM. 2002. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabetic Medicine 19:870-873. 21. Tanenberg RJ, Pfeifer, MA. 2000. Continuous glucose monitoring system: a new approach to the diagnosis of diabetic gastroparesis. Diabetes Technology & Therapeutics 2 (Suppl. 1):S73-80. 22. Oyib SO, Pradad YDM, Jackson NJ, Jude EB, Boulton AJM. 2001. Glycaemic excursions and painful diabetic peripheral neuropathy [abstract]. In: Diabetologia 44 (Suppl. 1):1149. 23. Tanenberg RJ, Scott CM, Andrus MA. 2002. Use of the Medtronic MiniMed CGMS in the diagnosis of diabetic gastroparesis [abstract]. In: Diabetes 51 (Suppl. 2): 2158. 24. Bode BW. 2000. New opportunities for therapeutic changes with continuous glucose sensing. Diabetes Spectrum 13 (3):171-174. 25. Bode BW. 2000. Clinical utility of the continuous glucose monitoring system. Diabetes Technology & Therapeutics 2 (Suppl. 1):S35-41. 26. Mastrototaro JJ. 1999. The MiniMed continuous glucose monitoring system (CGMS). Journal of Pediatric Endocrinology and Metabolism 12:751-758. 27. Mastrototaro JJ. 2000. The MiniMed continuous glucose monitoring system (CGMS). Diabetes Technology & Therapeutics 2 (Suppl 1):S13-18. 28. Rebrin, K and Steil, GM. 2000. Can interstitial glucose assessment replace blood glucose measurements? Diabetes Technology & Therapeutics 2 (No. 3):461-471. 29. Rebrin K, Steil GM, Van Antwerp WP, Mastrototaro JJ. 1999. Subcutaneous glucose predicts plasma glucose independent of insulin: implication for continuous monitoring. American Journal of Physiology 277 (Endocrinology and Metabolism 40): E561-E571. 30. Sadler CE, Einhorn D. 2000. Office Logistics: Implementation of the Continuous Glucose Monitoring System in Clinical Practice. Diabetes Technology & Therapeutics 2 (Suppl. 1):S89-91. 31. Skyler, JS. 2000. The economic burden of diabetes and the benefits of improved glycemic control: the potential role of a continuous glucose monitoring system. Diabetes Technology & Therapeutics 2 (Suppl. 1):S7-12. 32. Blumauer N, Steil GM, Voskanyan G, Mastrototaro J, Rebrin K. 2000. Continuous glucose monitoring following subcutaneous (sc) insulin injection [abstract]. In: Diabetes 49 (Suppl. 1):392. 33. Boyne MS, Silver DM., Kaplan J, Saudek CD. 2000. Timing of changes in interstitial and blood glucose measured with a continuous subcutaneous glucose sensor [abstract]. In: Diabetes 49 (Suppl. 1):398. 34. Djurhuus CB, Jungheim K, Gravholt CH, Kapitza C, Wientjes KJ, Koschinsky T, Heinemann L, Christiansen JS. 2002. Subcutaneous continuous glucose monitoring reveals insight into long-term management of diabetes through a tight correlation of time spent in hyperglycemia vs. HbA1c [abstract]. In: Diabetes 51 (Suppl. 2):388. 35. Einhorn D, Sadler C, Fink RI. 2000. New insights on glycemic control in the ambulatory setting: MiniMed's continuous glucose monitoring system [abstract]. In: Endocrine Society 82nd annual meeting program; 2000 Jun 21-24; Toronto. Canada. Abstract nr P 424. 36. Rebrin K, Panteleon AE, Long, KJ, Kolopp M, Steil GM. 2002. Establishing normal glucose dynamics as target for diabetes management by automated insulin infusion [abstract]. In: Diabetes 51 (Suppl. 2):455. 37. Rebrin K, Steil GM, Gross TM, Van Antwerp W, Mestman J, Mastrototaro JJ. 1999. Delay correction and smoothing of subcutaneous glucose sensor measurements [abstract]. In: Diabetes 48 (Suppl. 1):1587. 38. Sabbah H, McCulloch K, Fredrickson LP, Gross TM, Bode BW. 2000. Detailed data from a continuous glucose monitoring system (CGMS) facilitates comprehensive diabetes management recommendations [abstract]. Diabetes 49 (Suppl. 1):718. 39. Gross TM, Jeng LM, Davidson PC, Van Antwerp WP. 2001 A model of continuous glucose sensor data predicts HbA1c in type 1 versus type 2 diabetes [Abstract]. In: Diabetes 50 (Suppl 2):461 40. Levetan CS, Jeng LM, Thornton KR, Want LL, Ratner RE. 2001. When do glucose values best correlate with hemoglobin A1c [abstract] In: Diabetes 50 (Suppl. 2):496. 41. Phillips CA, Schaefer BJ, Danesh FR, Molitch ME. 2002. Evaluation of glucose excursions in diabetic patients on hemodialysis using the continuous glucose monitoring system [abstract]. In: Diabetes 51 (Suppl. 2): 506. 42. Ratner RE, Jeng LM, Want, LL, Levetan CS, Thornton KR. 2001. Identifying postprandial peaks using continuous glucose monitoring [abstract]. In: Diabetes 50 (Suppl. 2):517. 43. Steil GM, Blumauer N, Leech J, Long K, Panteleon AE, Rebrin K. 2001. Closed loop insulin delivery using subcutaneous (sc) glucose sensing and sc insulin delivery [abstract]. In: Diabetes 50 (Suppl. 2):533. 44. Wojcicki JM, Foltynski P, Ladyzynski P, Krzymien J, Karnafel W. 2002. A new method for the description of the continuously measured glycaemia courses [abstract]. In: Diabetes 51 (Suppl. 2):1986. 45. Jovanovic, L. 2000. The role of continuous glucose monitoring in gestational diabetes mellitus. Diabetes Technology & Therapeutics 2 (Suppl. 1):S67-71. 46. Buhling KJ, Engel B, Wolf C, Ilic S, Elsner E, Wascher C, Heinze T, Muller C, Siebert G, Dudenhausen JW. 2002. Influence of rich and low carbohydrate diet on the continuous glucose monitoring profile (CGMS, MiniMed) in healthy pregnant women and gestational diabetes [abstract]. In: Diabetes 51 (Suppl. 2):2550. 47. Ilic S, Jovanovic L, Jeng, L. 2001. What Is The Optimal Postprandial Glucose Monitoring System in Gestational Diabetes [abstract]. In: Diabetologia 43 (Suppl. 1):820. 48. Buhling KJ, Durzidim B, Wolf C, Ilic S, Wohlfarth K, Mahmaudi M, Dudensausen JW. 2001. Comparison of the hyperglycemia detection between the self monitoring of blood glucose (SMBG) and continuous blood glucose measurement system (CGMS; MiniMed) in gestational diabetic and non-diabetic pregnant women [abstract]. In: Diabetes 50 (Suppl. 2):1597. 49. Caplin NJ, O'Leary P, Bulsara M, Davis EA, Jones TW. 2003. Subcutaneous glucose sensor values closely parallel blood glucose during insulin-induced hypoglycemia. Diabetic Medicine 20:238-241. 50. Hirsch IB. 2001. Hypoglycemia and the hypoglycemic unawareness syndrome. Diabetes Technology & Therapeutics 2 (Suppl. 1):S81-87. 51. Broz J, Altannavch T, Andel M. 2001. Continuous glucose monitoring can help to decrease frequency of symptomatic hypoglycaemia in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion [abstract]. In: Diabetologia 44 (Suppl. 1):837. 52. Broz J, Andel M. 2002. Continuous glucose monitoring can help to decrease frequency of symptomatic hypoglycaemia in patients with type 1 diabetes treated with CSII in long term follow-up [abstract]. In: Diabetes (Suppl. 2):480. 53. Caplin NJ, Bulsara M, Jones TW, Davis EA. 2001. Subcutaneous glucose sensor values closely parallel blood glucose during hypoglycaemia [abstract]. In: Journal of Pediatric Endocrinology & Metabolism 13 (Suppl. 4):31. 54. Cheyne E, Everett J, Cavan D, Kerr D. 2000. Making sense of type 1 diabetes. unrecognized hypoglyceamia during continuous glucose sensing [abstract]. Diabetologia 43 (Suppl. 1):790. 55. Conrad SC, Mastrototaro JJ, Gitelman SE. 2001. Use of CGMS in the evaluation and treatment of hypoglycemic disorders [abstract]. In: Pediatric Research 49 (2-2):535. 56. Davidson PC, Sabbah H, McCulloch K, Bode BW. 2001. Reduction in severe hypoglycemia following use of continuous glucose monitoring: a pilot study [abstract]. In: Diabetologia 44 (Suppl. 1):836. 57. Deiss D, Meyer K, Kordonouri O, Danne T. 2000. Long hypoglycemic periods detected by continuous glucose monitoring in very young children with diabetes [abstract]. In: Journal of Pediatric Endocrinology & Metabolism 13 (Suppl. 4):70. 58. Gross TM, Mastrototaro J, Fredrickson LP. 2000. Detection of unseen hypoglycemia using continuous glucose monitoring [abstract]. In: Diabetologia 43 (Suppl. 1):19. 59. Gross TM, Jeng LM, Van Antwerp B, Fredrickson LP, Mastrototaro JJ. 2001. Hypo- and hyper- glycemic exposure estimates based on continuous glucose sensor data predict glycosylated hemoglobin [abstract]. In: Diabetologia 44 (Suppl. 1):170. 60. Gross TM, Ter Veer A, Jeng LM, Bode BW, Mastrototaro JJ. 2001. Is hypoglycemia detected by continuous glucose monitoring clinically valid [abstract]. In: Diabetes 50 (Suppl. 2):1871. 61. Gross TM, Van Antwerp B, Fredrickson LP, Mastrototaro JJ. 2002. Area under the curve analysis of CGMS profiles provides greater detail on hypo- and hyper- glycemic exposure than HbA1c [abstract]. In Diabetes 51 (Suppl. 2):493. 62. Howorka K, Pumpria J, Gabriel M, Grillmayr H. 2001. Patient treatment satisfaction is not affected by frequency of hypoglycaemia in type 1 diabetes: investigation with continuous subcutaneous blood glucose measurement [abstract]. In: Diabetologia 44 (Suppl. 1):838. 63. Kaufman FR, Halvorson M, Carpenter S, Neinstein A, Fisher LK, Devoe DJ, Pitukcheewanont P, Chang N. 2001. Noctural hypoglycemia (NH) detected with the continuous glucose monitoring system (CGMS) [abstract]. In: Diabetes 50 (Suppl. 2):1874. 64. Kerr D, Cheyne EH, Weiss M, Ryder J. 2001. Accuracy of MiniMed continuous glucose monitoring system during hypoglycaemia [abstract]. In: Diabetologia 44 (Suppl. 1):917. 65. Sabbah H, McCulloch K, Davidson PC, Bode BW. 2001. Reduction in severe hypoglycemia following use of continuous glucose monitoring to guide therapy adjustment : a pilot study [abstract]. In: Diabetes 50 (Suppl. 2):1877. 66. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. 1999. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Research and Clinical Practice 46:183-190. 67. Bode BW, Hirsch IB. 2000. Using the continuous glucose monitoring system to improve the management of type 1 diabetes. Diabetes Technology & Therapeutics 2 (Suppl. 1):S43-48. 68. Unger J. 2002. Case Study: A 62-year-old man with "brittle" type 1 diabetes. Clinical Diabetes 20(1):37-41. 69. Armstrong DU, King AB. 2002. Basal insulin: continuous glucose monitoring reveals less overnight hypoglycemia with continuous subcutaneous insulin infusion than with glargine [abstract]. In: Diabetes 51 (Suppl. 2): 373. 70. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. 2000. Continuous glucose monitoring facilitates sustainable improvements in glycemic control [abstract]. In: Diabetes 49 (Suppl. 1):393. 71. Bode BW, Sabbah H, McCulloch K. 2001. Continuous glucose monitoring facilitates lowering HbA1c levels in poorly controlled diabetes: results of a randomized controlled study [abstract]. In: Diabetes 50 (Suppl. 2):1795. 72. Hissa MN, Ter Veer A, Fredrickson L. 2001. Continuous glucose monitoring in therapy adjustment for patients with intensive insulin therapy [abstract]. In: Diabetes 50 (Suppl. 2):14. 73. King AB, Armstrong DU, Haller S, Gross TM, Fredrickson LP. 2002. Continuous glucose monitoring provides a novel method for evaluating rule-based estimates of insulin sensitivity [abstract]. In: Diabetes 51 (Suppl. 2):422. 74. Levin P, Yutzy P, Chez N, Modi P. 2001. Improved post-prandial glucose control with Oralin at breakfast, lunch and dinnertime [abstract]. In: Diabetes 50 (Suppl. 2):497. 75. Ludvigsson J, Hanas R, Ter Veer A, Andreasson C, Isacson E, Johansson E. 2001. Repeated use of continuous glucose monitoring in children and adolescents improved metabolic control without increasing hypoglycemia [abstract]. In: Diabetologia 44 (Suppl. 1):918. 76. Sabbah H, Bode BW, McCulloch K. 2001. A randomized, controlled study: use of a continuous glucose sensor improves HbA1c levels [abstract]. In: Diabetologia 44 (Suppl. 1):919. 77. Amin R, Ross K, Acerini CL, Edge JA, Warner J, Dunger DB. 2003. Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: using of continuous glucose monitoring system. Diabetes Care 26:662-667. 78. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. 2001. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 24(11):1858-1862. 79. Chase HP, Kim LM, Owen SL, MacKenzie TA, Klingersmith GJ, Murtfeld R, Garg SK. 2001. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics 107:222-226. 80. Kaufman FR. 2000. Role of continuous glucose monitoring in pediatric patients. Diabetes Technology & Therapeutics 2 (Suppl. 1):S49-52. 81. Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P. 2001. A pilot study of the continuous glucose monitoring system. Diabetes Care 24(12): 2030-2034. 82. Ludvigsson J, Isacson E. 2003. Clinical use of glucose sensors in the treatment of diabetes in children and adolescents. Pract Diab Int 20:7-12. 83. Salardi S, Zucchini S, Santoni R, Ragni L, Gualandi S, Cicognani A, Cacciari E. 2002. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA1c in pediatric type 1 diabetic patients. Diabetes Care 25(10):1840-1844. 84. Alemzadeh R, Loppnow C, Kirby M, Parton E, Haas P. 2002. Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus (DM) [abstract]. In: Diabetes 51 (Suppl. 2):478. 85. Austin J, Halvorson M, Cuthbertson D, Kaufman, FR. 2002. HbA1c correlated with Night (N) and pre and postmeal (PP) glucose levels in pediatric type 1 diabetes using the continuous glucose monitoring system (CGMS, MiniMed) [abstract]. In: Diabetes 51 (Suppl. 2):12. 86. Boland EA, Brandt CA, DeLucia M, Tamborlane WV. 2001. Making sense of glucose levels: use of continuous glucose sensors (CGMS) in children with type 1 diabetes [abstract]. In: Diabetes 50 (Suppl. 2):1579. 87. Boland EA, DeLucia M, Brandt CA, Ahern JJ, Tamborlane WV. 2002. Repeated use of the continuous glucose monitoring system (CGMS) in children with well-controlled T1DM decreases the frequency of nocturnal hypoglycemia without sacrificing metabolic control [abstract]. In: Diabetes 51 (Suppl. 2): 479. 88. Boland EA, DeLucia M, Brandt CA, Grey MJ, Tamborlane WV. 2000. Limitations of conventional methods of self blood glucose monitoring: lessons learned from three days of continuous glucose monitoring (CGMS) in pediatric patients with type 1 diabetes [abstract]. In: Diabetes 49 (Suppl. 1):397. 89. Caplin NJ, Jones TW, Davis EA. 2001. Continuous subcutaneous glucose monitoring in an infant with hyperinsulinaemia [abstract]. In: Pediatric Research 49 (2-2):536. 90. De Beaufort C, Schierloh U. 2001. Continuous glucose monitoring system: a considerable contribution to improve metabolic control [abstract]. In: Pediatric Research 49 (2-2):586. 91. Deiss D, Kordonouri O. 2001. Continuous glucose monitoring system in children with diabetes and multiple daily injections (MDI): postprandial glucose concentrations under therapy with short-acting analogs or regular insulin [abstract]. In: Pediatric Research 49 (2-2):566. 92. DeLucia MC, Boland EA, Brandt CA, Vasconcelos M, Tamborlane WV. 2002. How low (and high) can you go? Nighttime sensor glucose levels in healthy children [abstract]. In: Diabetes 51 (Suppl. 2):487. 93. Gibson LC, Halvorson MJ, Carpenter S, Kaufman FR. 2000. Short-term use of the MiniMedŽ continuous monitoring system to determine patterns of glycemia in pediatric patients with type 1 diabetes [abstract]. In: Diabetes 49 (Suppl. 1):438. 94. Halvorson MJ. 2000. Use of the MiniMedŽ continuous monitoring system in pediatric patients with type 1 diabetes [abstract]. In: Diabetes Research and Clinical Practice 50 (Suppl. 1):1379. 95. Phillip M, Benzaquen H, Shalitin S, Galatzer AN, Fayman G. 2001. Use of continuous subcutaneous glucose sensor for monitoring intensive diabetic control of children and adolescents with type 1 diabetes [abstract]. In: Pediatric Research 49 (2-2):568. 96. Pillar G, Shuscheim G, Weiss R, Nave T, Shehadeh N. 2001. The effects of blood glucose levels on the quality of sleep in children with type 1 diabetes mellitus [abstract]. In: Diabetologia 44 (Suppl. 1):249. 97. Schiaffini R, Ciampalini P, Spera S, Timpani S, Locatelli M, Borrelli P, Crino A. 2001. Detection of asymptomatic hypoglycaemic events by continuous glucose monitoring system (CGMS) in type 1 diabetic children [abstract]. In: Pediatric Research 49 (2-2):610. 98. Un Bae S, Tallian KB, Johnson S, Linarelli LG. 2001. Continuous glucose monitoring assessment before and after administration of metformin in patients with acanthosis nigricans [abstract]. In: Pediatric Research 49 (2-2):625. 99. Zangen DH, Weksler I, Levy F, Gillis D, Devries L, Phillip M. 2001. The use of continuous subcutaneous glucose monitoring system in hereditary persistent hyperinsulinemic hypoglycemia of infancy (PHHI) [abstract]. In: Pediatric Research 49 (2-2):528. PaediatricType 2 Diabetes Mellitus 100. Boland EA, Tamborlane WV. 2000. Continuous glucose monitoring in youth with type 2 diabetes: overcoming barriers to successful treatment. Diabetes Technology & Therapeutics 2 (Suppl. 1):S53-59. 101. Moghissi E, Mestman J. 2000. Type 2 diabetes mellitus. Diabetes Technology & Therapeutics 2 (Suppl. 1):S61-65. 102. Babu AR, Herdegen J, Kannan CR, Fogelfeld L, Shott S, Mazzone T. 2002. Treatment of obstructive sleep apnea with continuous positive airway pressure improves 24 hour glucose control [abstract]. In: Diabetes 51 (Suppl. 2):1911. 103. Bartolo P, Scaramuzza A, Miselli V, Brandolini S, Cannata F. 2002. A continuous glucose monitoring system in type 2 diabetics treated with LisPro mix 25 and premixed insulin 30/70 [abstract]. In: Diabetes 51(Suppl. 2):386. 104. Boullu-Sanchis S, Jeandidier N, Uhl C, Busch MS, Pinget M. 2001. Comparison of the efficacy of short term continuous infusion using either subcutaneous lispro insulin or intravenous regular insulin to improve blood glucose of uncontrolled type 2 diabetic patients [abstract]. In: Diabetes 50 (Suppl. 2):425. 105. Desouza C, Salazar H, Murgo J, Fonseca V. 2002. Association of hypoglycemia and cardiac ischemia: a study based on continuous glucose monitoring [abstract]. In: Diabetes 51 (Suppl. 2):589.
|
||||
|
© 2005, Copyright Medtronic. All rights reserved.
 |
||
|